Perioperative Infusion Management for Adhesive Bowel Obstruction with Congenital Nephrogenic Diabetes Insipidus: A Case Report.
diabetes insipidus
infusions
intravenous
nephrogenic
perioperative period
Journal
Yonago acta medica
ISSN: 0513-5710
Titre abrégé: Yonago Acta Med
Pays: Japan
ID NLM: 0414002
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
03
03
2023
accepted:
20
04
2023
medline:
25
5
2023
pubmed:
25
5
2023
entrez:
25
5
2023
Statut:
epublish
Résumé
Congenital nephrogenic diabetes insipidus (CNDI) is a rare disease that results in polyuria due to decreased responsiveness to the antidiuretic hormone in the collecting ducts of the kidney. Without compensation by drinking large amounts of water, dehydration and hypernatremia can rapidly develop. We present a case of a patient originally diagnosed with CNDI who required surgery and a fasting period due to adhesive bowel obstruction. The patient was a 46-year-old man who was originally diagnosed with CNDI. He was prescribed trichlormethiazide but self-discontinued treatment in the process. His normal urine output was about 7,000-8,000 mL/day. He underwent robot-assisted radical cystectomy and uretero-cutaneostomy for bladder cancer. Two years later, he was hospitalized due to adhesive bowel obstruction. A 5% glucose solution was infused, and the dose was adjusted according to the urine volume and electrolytes. An adhesiotomy was performed due to recurrent bowel obstruction in a short period of time. A 5% glucose solution was used as the main infusion during the perioperative period. Once drinking water was resumed after surgery, urinary output and electrolytes were easily controlled. In conclusion, patients with CNDI should be given a 5% glucose solution as the primary infusion, and the infusion volume should be adjusted by monitoring daily urine output, electrolytes, and blood glucose levels. Infusion management is easier if oral intake is initiated as early as possible.
Identifiants
pubmed: 37229364
doi: 10.33160/yam.2023.05.015
pii: 2023.05.015
pmc: PMC10203649
doi:
Types de publication
Case Reports
Langues
eng
Pagination
311-316Informations de copyright
©2023 Tottori University Medical Press.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
J Am Soc Nephrol. 2000 Jun;11(6):1044-1054
pubmed: 10820168
Clin Endocrinol (Oxf). 2019 Jan;90(1):23-30
pubmed: 30269342
Masui. 2001 Mar;50(3):287-9
pubmed: 11296443
J Mol Med (Berl). 1998 Apr;76(5):326-37
pubmed: 9587067
J Pediatr Endocrinol Metab. 2022 Feb 11;35(4):421-434
pubmed: 35146976
Mayo Clin Proc. 1990 Dec;65(12):1587-94
pubmed: 2255221
Curr Gastroenterol Rep. 2017 Jun;19(6):28
pubmed: 28439845
Yonago Acta Med. 2014 Jun;57(2):85-91
pubmed: 25324589
Ann Intern Med. 2006 Feb 7;144(3):186-94
pubmed: 16461963
N Engl J Med. 2015 Jan 1;372(1):55-65
pubmed: 25551526
Surgeon. 2005 Apr;3(2):89-94
pubmed: 15861943
Cureus. 2023 Feb 28;15(2):e35574
pubmed: 37007374
Nat Rev Nephrol. 2015 Oct;11(10):576-88
pubmed: 26077742